SCHEMBL31268989

SCHEMBL31268989

CC(CCOc1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2cccc(C(F)(F)F)c2)c(Cl)c1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 5/20 0.40
▸ S1PR5 Q9H228 5/20 0.40
▸ PDGFRA P16234 2/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PRKD3 O94806 1/20 0.37
▸ CDK7 P50613 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ TNK2 Q07912 1/20 0.37
▸ PRKX P51817 1/20 0.35
▸ IKBKE Q14164 1/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ P2RX3 P56373 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ ACACB O00763 2/20 0.34
▸ HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268742 1.00 S1PR1 (0.40) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31268807 0.96 S1PR1 (0.36) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31268790 0.96 S1PR1 (0.36) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31269263 0.95 S1PR1 (0.34) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31269301 0.93 S1PR1 (0.35) S1PR1KMT2APIK3CDACACB
SCHEMBL30983474 0.93 CNR1 (0.35) S1PR1S1PR5KMT2ALMNAPIK3CD
SCHEMBL30983374 0.93 CNR1 (0.35) S1PR1S1PR5KMT2ALMNAPIK3CD
SCHEMBL30983500 0.93 CNR1 (0.35) S1PR1S1PR5KMT2ALMNAPIK3CD
SCHEMBL31268822 0.92 SCN1A (0.35) S1PR1S1PR5PDGFRAPIM1KMT2A
SCHEMBL31269103 0.91 ALOX5AP (0.33) S1PR1KMT2APIK3CDALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback